Drugs / CD133+
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03803241 | May 2019 → Dec 2020 | colorectal cancer | Hospital San Carlos, Madrid | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD133+ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03803241 ↗ |
| Modality | Cell therapy | “CD133 + stem cells” PMID 32561087 ↗ Oct 2019 |
| Route | Other | “intrahepatic infusion” PMID 32561087 ↗ Oct 2019 |